News
Gene editing and many other useful biotechnology tools came from studies of bacteria fighting off viral invaders. But ...
The government already struggles to find licensees for many of its inventions, and adding more red tape in the form of the ...
Lawsuits against pharmacies in seven states aim to protect its flagship Mounjaro and Zepbound medications | Growing ...
8d
How-To Geek on MSNThe Quiet Revolution of Synthetic BiologyLater, Wacław Szybalski popularized the term in 1974 in reference to genetic engineering, but little did he know that one day ...
The sudden departure of Peter Marks, MD, from the FDA has prompted a chorus of criticism and despair from industry leaders and trade organizations.
ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Jumpcode Genomics ('Jumpcode'), a life science tools company ...
Epicrispr Biotechnologies to Begin Clinical Trials for its Lead Epigenetic Therapy for FSHD Patients
The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.
The startup is using CRISPR tools to stop errant expression of a gene linked to facioscapulohumeral muscular dystrophy, a ...
Expanding CRISPR's Potential Since its discovery, CRISPR (“Clustered Regularly Interspaced Short Palindromic Repeats”), which ...
CRISPR Therapeutics poised for growth with international potential and clinical assets. Read why I rate CRSP stock a Strong Buy right now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results